Global Dextran Market research

Dextran Comprehensive Study by Type (Dextran 20, Dextran 40, Dextran 60, Dextran 70, Other), Application (Solutions for Injection and Infusion, Dextran Derivative, Other) Players and Region - Global Market Outlook to 2028

Dextran Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Dextran Market Scope
Dextran is a complex glucan, a polysaccharide derived from the condensation of glucose, composed of chains of varying length. It is produced from sucrose by certain lactic acid bacteria of the lactobacillus. Species used to produce the dextran are Leuconostoc mesenteroides and Streptococcus mutans. Medicinally dextran is used as an antithrombotic to reduce blood viscosity and as a volume expander in hypovolemia. It is used in some eye drops as a lubricant. It has many health benefits. It contributes to many more applications in technical and pharmaceutical industries.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledSigma-Aldrich (United States), Pharmacosmos (Denmark), Pfizer (United States), Herbon International Holdings Co. Ltd. (China), Meito Sangyo Co., Ltd. (Japan), Polydex Pharmaceuticals Limited (Canada), Shanghai Huamao Pharmaceutical Co., Ltd. (China), pK Chemicals (Denmark), Nacalai Tesque, Inc. (Japan) and VWR International (United States)
CAGR%


Dextran is highly competitive, with several key players dominating the industry. The market players are focused on developing a variety of features and benefits to meet the needs and preferences of consumers. Thus, constantly introducing new innovation in processing to meet the changing needs and preferences of consumers. The companies are also planning strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Research Analyst at AMA estimates that Global Vendors will contribute to the maximum growth of Global Dextran market throughout the predicted period.

Sigma-Aldrich (United States), Pharmacosmos (Denmark), Pfizer (United States), Herbon International Holdings Co. Ltd. (China), Meito Sangyo Co., Ltd. (Japan), Polydex Pharmaceuticals Limited (Canada), Shanghai Huamao Pharmaceutical Co., Ltd. (China), pK Chemicals (Denmark), Nacalai Tesque, Inc. (Japan) and VWR International (United States) are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Dextran market by Type , by Application (Solutions for Injection and Infusion, Dextran Derivative and Other) and Region with country level break-up.

On the basis of geography, the market of Dextran has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2022.

Market Leaders and their expansionary development strategies
In May 2023, Dextran sulfate from Leuconostoc mesenteroides B512F exerts potent antiviral activity against SARS-CoV-2 in vitro and in vivo. Dextran sulfate (DS) polysaccharides have long demonstrated antiviral activity against different enveloped viruses in vitro.
In September 2019, Pharmacosmos, a world leader in developing and producing carbohydrates for pharmaceutical applications, has registered Pharmaceutical Quality Dextran 40 EP Monograph and Dextran 70 EP Monograph as excipients in China. The registrations are published on the CFDA website and can be referenced through a letter of access when the Dextran is used as excipients in final products.


Influencing Trend:
Demand for Products with Improved Features

Market Growth Drivers:
Health Benefits of the Dextran and Increasing Demand for Ophthalmic Use

Challenges:
Low Availability in the Market

Restraints:
Side Effects of the Dextran

Opportunities:
Rising Demand from End-User Industry and Growing Pharmaceutical Industry Worldwide

Key Target Audience
Dextran Manufacturers, Distributors, Research Professionals, Emerging Companies, Government Body & Associations and End-user

Report Objectives / Segmentation Covered

By Type
  • Dextran 20
  • Dextran 40
  • Dextran 60
  • Dextran 70
  • Other
By Application
  • Solutions for Injection and Infusion
  • Dextran Derivative
  • Other
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Health Benefits of the Dextran
      • 3.2.2. Increasing Demand for Ophthalmic Use
    • 3.3. Market Challenges
      • 3.3.1. Low Availability in the Market
    • 3.4. Market Trends
      • 3.4.1. Demand for Products with Improved Features
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Dextran, by Type, Application and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Dextran (Value)
      • 5.2.1. Global Dextran by: Type (Value)
        • 5.2.1.1. Dextran 20
        • 5.2.1.2. Dextran 40
        • 5.2.1.3. Dextran 60
        • 5.2.1.4. Dextran 70
        • 5.2.1.5. Other
      • 5.2.2. Global Dextran by: Application (Value)
        • 5.2.2.1. Solutions for Injection and Infusion
        • 5.2.2.2. Dextran Derivative
        • 5.2.2.3. Other
      • 5.2.3. Global Dextran Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Dextran: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sigma-Aldrich (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pharmacosmos (Denmark)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Pfizer (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Herbon International Holdings Co. Ltd. (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Meito Sangyo Co., Ltd. (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Polydex Pharmaceuticals Limited (Canada)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Shanghai Huamao Pharmaceutical Co., Ltd. (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. PK Chemicals (Denmark)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Nacalai Tesque, Inc. (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. VWR International (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Dextran Sale, by Type, Application and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Dextran (Value)
      • 7.2.1. Global Dextran by: Type (Value)
        • 7.2.1.1. Dextran 20
        • 7.2.1.2. Dextran 40
        • 7.2.1.3. Dextran 60
        • 7.2.1.4. Dextran 70
        • 7.2.1.5. Other
      • 7.2.2. Global Dextran by: Application (Value)
        • 7.2.2.1. Solutions for Injection and Infusion
        • 7.2.2.2. Dextran Derivative
        • 7.2.2.3. Other
      • 7.2.3. Global Dextran Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Dextran: by Type(USD Million)
  • Table 2. Dextran Dextran 20 , by Region USD Million (2017-2022)
  • Table 3. Dextran Dextran 40 , by Region USD Million (2017-2022)
  • Table 4. Dextran Dextran 60 , by Region USD Million (2017-2022)
  • Table 5. Dextran Dextran 70 , by Region USD Million (2017-2022)
  • Table 6. Dextran Other , by Region USD Million (2017-2022)
  • Table 7. Dextran: by Application(USD Million)
  • Table 8. Dextran Solutions for Injection and Infusion , by Region USD Million (2017-2022)
  • Table 9. Dextran Dextran Derivative , by Region USD Million (2017-2022)
  • Table 10. Dextran Other , by Region USD Million (2017-2022)
  • Table 11. South America Dextran, by Country USD Million (2017-2022)
  • Table 12. South America Dextran, by Type USD Million (2017-2022)
  • Table 13. South America Dextran, by Application USD Million (2017-2022)
  • Table 14. Brazil Dextran, by Type USD Million (2017-2022)
  • Table 15. Brazil Dextran, by Application USD Million (2017-2022)
  • Table 16. Argentina Dextran, by Type USD Million (2017-2022)
  • Table 17. Argentina Dextran, by Application USD Million (2017-2022)
  • Table 18. Rest of South America Dextran, by Type USD Million (2017-2022)
  • Table 19. Rest of South America Dextran, by Application USD Million (2017-2022)
  • Table 20. Asia Pacific Dextran, by Country USD Million (2017-2022)
  • Table 21. Asia Pacific Dextran, by Type USD Million (2017-2022)
  • Table 22. Asia Pacific Dextran, by Application USD Million (2017-2022)
  • Table 23. China Dextran, by Type USD Million (2017-2022)
  • Table 24. China Dextran, by Application USD Million (2017-2022)
  • Table 25. Japan Dextran, by Type USD Million (2017-2022)
  • Table 26. Japan Dextran, by Application USD Million (2017-2022)
  • Table 27. India Dextran, by Type USD Million (2017-2022)
  • Table 28. India Dextran, by Application USD Million (2017-2022)
  • Table 29. South Korea Dextran, by Type USD Million (2017-2022)
  • Table 30. South Korea Dextran, by Application USD Million (2017-2022)
  • Table 31. Taiwan Dextran, by Type USD Million (2017-2022)
  • Table 32. Taiwan Dextran, by Application USD Million (2017-2022)
  • Table 33. Australia Dextran, by Type USD Million (2017-2022)
  • Table 34. Australia Dextran, by Application USD Million (2017-2022)
  • Table 35. Rest of Asia-Pacific Dextran, by Type USD Million (2017-2022)
  • Table 36. Rest of Asia-Pacific Dextran, by Application USD Million (2017-2022)
  • Table 37. Europe Dextran, by Country USD Million (2017-2022)
  • Table 38. Europe Dextran, by Type USD Million (2017-2022)
  • Table 39. Europe Dextran, by Application USD Million (2017-2022)
  • Table 40. Germany Dextran, by Type USD Million (2017-2022)
  • Table 41. Germany Dextran, by Application USD Million (2017-2022)
  • Table 42. France Dextran, by Type USD Million (2017-2022)
  • Table 43. France Dextran, by Application USD Million (2017-2022)
  • Table 44. Italy Dextran, by Type USD Million (2017-2022)
  • Table 45. Italy Dextran, by Application USD Million (2017-2022)
  • Table 46. United Kingdom Dextran, by Type USD Million (2017-2022)
  • Table 47. United Kingdom Dextran, by Application USD Million (2017-2022)
  • Table 48. Netherlands Dextran, by Type USD Million (2017-2022)
  • Table 49. Netherlands Dextran, by Application USD Million (2017-2022)
  • Table 50. Rest of Europe Dextran, by Type USD Million (2017-2022)
  • Table 51. Rest of Europe Dextran, by Application USD Million (2017-2022)
  • Table 52. MEA Dextran, by Country USD Million (2017-2022)
  • Table 53. MEA Dextran, by Type USD Million (2017-2022)
  • Table 54. MEA Dextran, by Application USD Million (2017-2022)
  • Table 55. Middle East Dextran, by Type USD Million (2017-2022)
  • Table 56. Middle East Dextran, by Application USD Million (2017-2022)
  • Table 57. Africa Dextran, by Type USD Million (2017-2022)
  • Table 58. Africa Dextran, by Application USD Million (2017-2022)
  • Table 59. North America Dextran, by Country USD Million (2017-2022)
  • Table 60. North America Dextran, by Type USD Million (2017-2022)
  • Table 61. North America Dextran, by Application USD Million (2017-2022)
  • Table 62. United States Dextran, by Type USD Million (2017-2022)
  • Table 63. United States Dextran, by Application USD Million (2017-2022)
  • Table 64. Canada Dextran, by Type USD Million (2017-2022)
  • Table 65. Canada Dextran, by Application USD Million (2017-2022)
  • Table 66. Mexico Dextran, by Type USD Million (2017-2022)
  • Table 67. Mexico Dextran, by Application USD Million (2017-2022)
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Dextran: by Type(USD Million)
  • Table 79. Dextran Dextran 20 , by Region USD Million (2023-2028)
  • Table 80. Dextran Dextran 40 , by Region USD Million (2023-2028)
  • Table 81. Dextran Dextran 60 , by Region USD Million (2023-2028)
  • Table 82. Dextran Dextran 70 , by Region USD Million (2023-2028)
  • Table 83. Dextran Other , by Region USD Million (2023-2028)
  • Table 84. Dextran: by Application(USD Million)
  • Table 85. Dextran Solutions for Injection and Infusion , by Region USD Million (2023-2028)
  • Table 86. Dextran Dextran Derivative , by Region USD Million (2023-2028)
  • Table 87. Dextran Other , by Region USD Million (2023-2028)
  • Table 88. South America Dextran, by Country USD Million (2023-2028)
  • Table 89. South America Dextran, by Type USD Million (2023-2028)
  • Table 90. South America Dextran, by Application USD Million (2023-2028)
  • Table 91. Brazil Dextran, by Type USD Million (2023-2028)
  • Table 92. Brazil Dextran, by Application USD Million (2023-2028)
  • Table 93. Argentina Dextran, by Type USD Million (2023-2028)
  • Table 94. Argentina Dextran, by Application USD Million (2023-2028)
  • Table 95. Rest of South America Dextran, by Type USD Million (2023-2028)
  • Table 96. Rest of South America Dextran, by Application USD Million (2023-2028)
  • Table 97. Asia Pacific Dextran, by Country USD Million (2023-2028)
  • Table 98. Asia Pacific Dextran, by Type USD Million (2023-2028)
  • Table 99. Asia Pacific Dextran, by Application USD Million (2023-2028)
  • Table 100. China Dextran, by Type USD Million (2023-2028)
  • Table 101. China Dextran, by Application USD Million (2023-2028)
  • Table 102. Japan Dextran, by Type USD Million (2023-2028)
  • Table 103. Japan Dextran, by Application USD Million (2023-2028)
  • Table 104. India Dextran, by Type USD Million (2023-2028)
  • Table 105. India Dextran, by Application USD Million (2023-2028)
  • Table 106. South Korea Dextran, by Type USD Million (2023-2028)
  • Table 107. South Korea Dextran, by Application USD Million (2023-2028)
  • Table 108. Taiwan Dextran, by Type USD Million (2023-2028)
  • Table 109. Taiwan Dextran, by Application USD Million (2023-2028)
  • Table 110. Australia Dextran, by Type USD Million (2023-2028)
  • Table 111. Australia Dextran, by Application USD Million (2023-2028)
  • Table 112. Rest of Asia-Pacific Dextran, by Type USD Million (2023-2028)
  • Table 113. Rest of Asia-Pacific Dextran, by Application USD Million (2023-2028)
  • Table 114. Europe Dextran, by Country USD Million (2023-2028)
  • Table 115. Europe Dextran, by Type USD Million (2023-2028)
  • Table 116. Europe Dextran, by Application USD Million (2023-2028)
  • Table 117. Germany Dextran, by Type USD Million (2023-2028)
  • Table 118. Germany Dextran, by Application USD Million (2023-2028)
  • Table 119. France Dextran, by Type USD Million (2023-2028)
  • Table 120. France Dextran, by Application USD Million (2023-2028)
  • Table 121. Italy Dextran, by Type USD Million (2023-2028)
  • Table 122. Italy Dextran, by Application USD Million (2023-2028)
  • Table 123. United Kingdom Dextran, by Type USD Million (2023-2028)
  • Table 124. United Kingdom Dextran, by Application USD Million (2023-2028)
  • Table 125. Netherlands Dextran, by Type USD Million (2023-2028)
  • Table 126. Netherlands Dextran, by Application USD Million (2023-2028)
  • Table 127. Rest of Europe Dextran, by Type USD Million (2023-2028)
  • Table 128. Rest of Europe Dextran, by Application USD Million (2023-2028)
  • Table 129. MEA Dextran, by Country USD Million (2023-2028)
  • Table 130. MEA Dextran, by Type USD Million (2023-2028)
  • Table 131. MEA Dextran, by Application USD Million (2023-2028)
  • Table 132. Middle East Dextran, by Type USD Million (2023-2028)
  • Table 133. Middle East Dextran, by Application USD Million (2023-2028)
  • Table 134. Africa Dextran, by Type USD Million (2023-2028)
  • Table 135. Africa Dextran, by Application USD Million (2023-2028)
  • Table 136. North America Dextran, by Country USD Million (2023-2028)
  • Table 137. North America Dextran, by Type USD Million (2023-2028)
  • Table 138. North America Dextran, by Application USD Million (2023-2028)
  • Table 139. United States Dextran, by Type USD Million (2023-2028)
  • Table 140. United States Dextran, by Application USD Million (2023-2028)
  • Table 141. Canada Dextran, by Type USD Million (2023-2028)
  • Table 142. Canada Dextran, by Application USD Million (2023-2028)
  • Table 143. Mexico Dextran, by Type USD Million (2023-2028)
  • Table 144. Mexico Dextran, by Application USD Million (2023-2028)
  • Table 145. Research Programs/Design for This Report
  • Table 146. Key Data Information from Secondary Sources
  • Table 147. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Dextran: by Type USD Million (2017-2022)
  • Figure 5. Global Dextran: by Application USD Million (2017-2022)
  • Figure 6. South America Dextran Share (%), by Country
  • Figure 7. Asia Pacific Dextran Share (%), by Country
  • Figure 8. Europe Dextran Share (%), by Country
  • Figure 9. MEA Dextran Share (%), by Country
  • Figure 10. North America Dextran Share (%), by Country
  • Figure 11. Global Dextran share by Players 2022 (%)
  • Figure 12. Global Dextran share by Players (Top 3) 2022(%)
  • Figure 13. Global Dextran share by Players (Top 5) 2022(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Sigma-Aldrich (United States) Revenue, Net Income and Gross profit
  • Figure 16. Sigma-Aldrich (United States) Revenue: by Geography 2022
  • Figure 17. Pharmacosmos (Denmark) Revenue, Net Income and Gross profit
  • Figure 18. Pharmacosmos (Denmark) Revenue: by Geography 2022
  • Figure 19. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 20. Pfizer (United States) Revenue: by Geography 2022
  • Figure 21. Herbon International Holdings Co. Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 22. Herbon International Holdings Co. Ltd. (China) Revenue: by Geography 2022
  • Figure 23. Meito Sangyo Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 24. Meito Sangyo Co., Ltd. (Japan) Revenue: by Geography 2022
  • Figure 25. Polydex Pharmaceuticals Limited (Canada) Revenue, Net Income and Gross profit
  • Figure 26. Polydex Pharmaceuticals Limited (Canada) Revenue: by Geography 2022
  • Figure 27. Shanghai Huamao Pharmaceutical Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 28. Shanghai Huamao Pharmaceutical Co., Ltd. (China) Revenue: by Geography 2022
  • Figure 29. PK Chemicals (Denmark) Revenue, Net Income and Gross profit
  • Figure 30. PK Chemicals (Denmark) Revenue: by Geography 2022
  • Figure 31. Nacalai Tesque, Inc. (Japan) Revenue, Net Income and Gross profit
  • Figure 32. Nacalai Tesque, Inc. (Japan) Revenue: by Geography 2022
  • Figure 33. VWR International (United States) Revenue, Net Income and Gross profit
  • Figure 34. VWR International (United States) Revenue: by Geography 2022
  • Figure 35. Global Dextran: by Type USD Million (2023-2028)
  • Figure 36. Global Dextran: by Application USD Million (2023-2028)
  • Figure 37. South America Dextran Share (%), by Country
  • Figure 38. Asia Pacific Dextran Share (%), by Country
  • Figure 39. Europe Dextran Share (%), by Country
  • Figure 40. MEA Dextran Share (%), by Country
  • Figure 41. North America Dextran Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Sigma-Aldrich (United States)
  • Pharmacosmos (Denmark)
  • Pfizer (United States)
  • Herbon International Holdings Co. Ltd. (China)
  • Meito Sangyo Co., Ltd. (Japan)
  • Polydex Pharmaceuticals Limited (Canada)
  • Shanghai Huamao Pharmaceutical Co., Ltd. (China)
  • pK Chemicals (Denmark)
  • Nacalai Tesque, Inc. (Japan)
  • VWR International (United States)
Select User Access Type

Key Highlights of Report


Dec 2023 231 Pages 68 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Dextran Market research Quantitative research analysis
Global Dextran Market research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Dextran Market are by type [Dextran 20, Dextran 40, Dextran 60, Dextran 70 and Other], by end use application [Solutions for Injection and Infusion, Dextran Derivative and Other].
The Dextran Market is gaining popularity and expected to see strong valuation by 2028.
  • Health Benefits of the Dextran
  • Increasing Demand for Ophthalmic Use

Know More About Global Dextran Market research Report?

Have a Query? Click Here

Other Related Reports

Epoxy Resin Comprehensive Study by Type (Rubber Modified, Urethane Modified, Dimer Acid Modified), Application (Paints & Coatings, Adhesives, Composites, Electrical Laminates, Paint & Coating, Floori...
$ 3800
PVC Jacketing Comprehensive Study by Application (Indoors, Outdoors), Thickness (0.015’’, 0.020’’, 0.030’’), End-User Industries (Food Processing, Beverage, Appliance Wiring Industry, Others) Players...
$ 3500
Boiler Corrosion Inhibitor Comprehensive Study by Type (Organic Corrosion Inhibitor, Inorganic Corrosion Inhibitor), Application (Power, Oil & Gas, Chemical & Petrochemical, Food & Beverage, Pulp & P...
$ 3750
Coal Tar Creosote Comprehensive Study by Application (Antiseptic, Wood Preservative, Carbon Black, Others), Sales Channels (Direct, Indirect), Oil (Light Creosote Oil, Heavy Creosote Oil) Players and...
$ 3500
Cosmetic Preservative Blends Comprehensive Study by Type (Parabens, Organic Acids, Formaldahyde Releasers, Isothiazolinones, Phenoxyethanol), Application (Personal Care, Beauty Care), Distribution Ch...
$ 3350
Antimicrobial Plastics Comprehensive Study by Type (Commodity Plastics {Polyethylene, Polypropylene, Polystyrene, Polyvinyl Chloride, Polymethyl methacrylate, Polyethylene Terephthalate, Polyurethane...
$ 3750